Mental Health Clinics in Lakeville, CT Accepting Medicare
5 Mental Health Clinics found. Showing 1 - 5
 Northwest Center For Family Service And Mental Health, Inc. Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 315 Main St, Lakeville, CT 06039 Phone: 860-435-2529 |
Marietta Whittlesey Lpc Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 184 Main St, Lakeville, CT 06039 Phone: 860-435-2777 Fax: 860-435-2777 |
Ruth Trudeau, Lmft, Ladc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 15 Porter St, Lakeville, CT 06039 Phone: 860-435-3505 Fax: 860-435-3505 |
Marjorie A. Arni Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 308 Main St, Lakeville, Lakeville, CT 06039 Phone: 860-671-9277 Fax: 860-364-5718 |
Emily Midwood,lcsw Pllc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 348 Main St, Lakeville, CT 06039 Phone: 413-225-1477 |
News Archive
Study finds link between musical activity and high cognitive aging
A study conducted by Brenda Hanna-Pladdy, PhD, a clinical neuropsychologist in Emory's Department of Neurology, and cognitive psychologist Alicia MacKay, PhD, found that older individuals who spent a significant amount of time throughout life playing a musical instrument perform better on some cognitive tests than individuals who did not play an instrument.
FDA allows flexible storage and transportation conditions for Pfizer-Biontech COVID-19 vaccine
Today, the U.S. Food and Drug Administration announced that it is allowing undiluted frozen vials of the Pfizer-BioNTech COVID-19 Vaccine to be transported and stored at conventional temperatures commonly found in pharmaceutical freezers for a period of up to two weeks.
Targeting invasive cells could be a new strategy to treat metastatic cancer, say Stony Brook researchers
Most cancer drugs are designed to target dividing cells, but a new study by Stony Brook University researchers suggests that targeting invasive cells may be a new strategy to treat metastatic cancer.
CMD co-founder receives Prize4Life award for discovery of new ALS biomarker
Convergence Medical Devices (CMD) today announced that its co-founder, Dr. Seward Rutkove, Chief of the Division of Neuromuscular Disease at Beth Israel Deaconess Medical Center and Associate Professor of Neurology at Harvard Medical School, received Prize4Life's prestigious award for the discovery of a new biomarker for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease.
Novelos reports positive results from NOV-002 Phase 2 neoadjuvant breast cancer trial
Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer and hepatitis, today announced positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer, conducted by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.
› Verified 6 days ago